- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| Do | Aditxt beruft Jeff Busch an die Spitze der Tochtergesellschaft Ignite Proteomics | 1 | Investing.com Deutsch | ||
| Do | Aditxt names Jeff Busch CEO of Ignite Proteomics subsidiary | 2 | Investing.com | ||
| 13.03. | Aditxt acquires Ignite Proteomics in $36M preferred stock deal; shares down | 1 | Seeking Alpha | ||
| IMAC HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 13.03. | Aditxt acquires precision oncology firm Ignite Proteomics | 2 | Investing.com | ||
| 13.03. | Aditxt übernimmt Präzisionsonkologie-Unternehmen Ignite Proteomics | 2 | Investing.com Deutsch | ||
| 27.02. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.02. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 30.01. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.01. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 17.12.25 | IMAC Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 16.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 01.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.11.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | IMAC Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 31.10.25 | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.10.25 | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.09.25 | IMAC Holdings, Inc.: Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers | 176 | GlobeNewswire (Europe) | The First Precision Oncology Trial to Use a Functional Proteomics and Phosphoproteomics Assay for Treatment Decision Making in a Pan-Tumor Study Golden, CO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ignite... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 0,247 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide May Reduce Leptomeningeal Metastases Healthcare Costs by 40% | ||
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| LIFEWARD | 6,900 | 0,00 % | Lifeward Ltd.: Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results | Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive Oramed strategic transaction receives shareholder approval- Lifeward gains new... ► Artikel lesen | |
| EKSO BIONICS | 10,640 | 0,00 % | Applied Digital Corporation: Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale | DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Applied Digital (NASDAQ: APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial... ► Artikel lesen | |
| IMUNON | 2,280 | -1,72 % | Imunon erweitert At-the-Market-Offering um 7 Millionen US-Dollar | ||
| ROCKWELL MEDICAL | 0,875 | -0,40 % | Why Is Rockwell Medical Gaining Tuesday? | ||
| VIRIDIAN THERAPEUTICS | 23,340 | -0,26 % | Viridian Therapeutics stellt auf TD Cowen Konferenz Strategie für TED-Behandlung vor | ||
| SINTX TECHNOLOGIES | 2,550 | +2,41 % | SINTX Technologies, Inc.: SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution | Clinical milestone, new President appointment, and platform expansion position SINTX for commercial rollout and revenue growth in 2026 SALT LAKE CITY, Utah, March 23, 2026 (GLOBE NEWSWIRE) -- SINTX... ► Artikel lesen | |
| AETHLON MEDICAL | 2,170 | +0,46 % | AETHLON MEDICAL INC - 8-K, Current Report | ||
| NEURONETICS | 1,388 | +11,04 % | Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results | Total revenue of $41.8 million in Q4 2025, up 86% as reported and 23% on an adjusted pro forma basis versus Q4 2024 Greenbrook clinic revenue of $23.5 million in Q4 2025, up 428% as reported and 37%... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | StageZero Life Sciences Ltd.: StageZero Announces Partial Revocation of Failure to File Cease Trade Order and Proposed Financing | ||
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 15-12G, Securities registration termination | ||
| HVIVO | 0,076 | 0,00 % | hVIVO PLC - Issue of Equity and Total Voting Rights | ||
| FRESENIUS | 44,000 | +0,71 % | PRESSESPIEGEL/Unternehmen: COMMERZBANK, DEUTSCHE BANK, FRESENIUS, DEUTSCHE BAHN | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
COMMERZBANK - Der Commerzbank-Betriebsrat verschärft im Übernahmekampf... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 36,660 | +0,30 % | EQS-DD: Siemens Healthineers AG: Dorothea Simon, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
20.03.2026 / 16:23... ► Artikel lesen |
IMAC HOLDINGS INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,008 (-4,00 %) liegt der Kurs bei 0,192 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IMAC HOLDINGS INC finden Sie auf Wallstreet Online.